Concurrent Session 3A: Abstract Session - Progress and Priorities in the Hepatitis B Response
Tracks
​
| Thursday, August 7, 2025 |
| 2:30 PM - 3:30 PM |
| Ballroom 3 |
Speaker
​
Welcome & Introduction
2:30 PM - 2:35 PMBiography
Dr Elizabeth Hamilton
Honorary
WHO Collaborating Centre for Viral Hepatitis, Doherty Institute
Keeping track of real progress – updating the population impact of hepatitis B treatment as we strive for elimination
2:35 PM - 2:50 PMBiography
Beth is currently an advanced trainee in public health medicine in NSW. She is a Honorary Senior Fellow at the Royal Melbourne Hospital Infectious Disease department, conducting hepatitis B related research in Professor Cowie's team. She previously completed a DPhil investigating chronic hepatitis B burden in China, through Oxford University.
Dr Behzad Hajarizadeh
Associate Professor
Unsw/ Kirby Institute
Antiviral treatment uptake and factors associated with treatment among people receiving clinical care for chronic hepatitis B in Australia: The REACH-B Study
2:50 PM - 3:05 PMBiography
Behzad is a clinical epidemiologist, an Associate Professor in the Kirby Institute (UNSW) and an NHMRC fellow. His academic focus is on public health and clinical research on viral hepatitis.
David Carter
Scientia Associate Professor
Unsw Sydney
The legal needs and experiences of people living with hepatitis B in Australia – findings from Australia’s first national study of the legal needs of people with blood-borne viruses
3:05 PM - 3:20 PMBiography
David is an Australian lawyer and expert in the field of medical and health law. He leads the Health+Law Resarch Partnership which aims to improve access to justice and quality of life for those living with Hepatitis B.
Dr Behzad Hajarizadeh
Associate Professor
Unsw/ Kirby Institute
Acceptability and preference of point-of-care finger-prick capillary whole-blood and venipuncture tests for hepatitis B viral load among people living with chronic hepatitis B
3:20 PM - 3:25 PMBiography
Behzad is a clinical epidemiologist, an Associate Professor in the Kirby Institute (UNSW) and an NHMRC fellow. His academic focus is on public health and clinical research on viral hepatitis.
Ms Michelle Kudell
Programs Director
Hepatitis Australia
HepLink Australia: Commonwealth funding community to advance the national response
3:25 PM - 3:30 PMBiography
Michelle is the Programs Director at Hepatitis Australia. She brings decades of experience leading community responses in viral hepatitis, alcohol and other drugs and Aboriginal and Torres Strait Islander health, as well as significant experience in design and commissioning of services through Primary Health Networks in Australia.
Chairperson
Jane Davies
Senior Principal Research Fellow, Co-director Infectious Diseases
Menzies School Of Health Research/nt Health
Jack Wallace
Senior Research Officer
Burnet Institute
